These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2944846)

  • 1. Induction of suppressor cells in normal lymphocytes by uremic serum.
    Weissgarten J; Modai D; Cohen N; Averbukh Z; Shaked U; Tieder M; Peller S; Kaufman S
    Int Arch Allergy Appl Immunol; 1986; 81(2):180-3. PubMed ID: 2944846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of suppressor cell activity in normal peripheral blood mononuclear cells by sera from predialytic uremic patients.
    Modai D; Berman S; Weissgarten J; Klinovsky E; Cohn M; Averbukh Z
    Int Arch Allergy Appl Immunol; 1990; 92(3):268-71. PubMed ID: 2148928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemodialysis on T lymphocyte subsets, con-A-activated suppressor cell activity, and interleukin-2 receptor expression on lymphocytes in chronic uremic patients.
    Tchórzewski H; Luciak M; Trznadel K; Majewska E; Pokoca L
    Artif Organs; 1989 Jun; 13(3):185-9. PubMed ID: 2527490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective radioresistant suppressor cell activity in hemodialysis patients.
    Mirapeix E; Montoliu J; Suárez C; López Pedret J; Revert L
    Nephron; 1985; 41(2):184-8. PubMed ID: 2931611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune function in uremia: altered cytotoxic and suppressor cell responses to an immunomodulating heptapeptide.
    Rola-Pleszczynski M; Bolduc D; Forand S; Plante GE; St-Pierre S
    Clin Immunol Immunopathol; 1983 Aug; 28(2):177-84. PubMed ID: 6223765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of uremic sera on the blastic transformation of lymphocytes of healthy subjects, stimulated with non-specific mitogens (PHA, con A, PWM).
    Klinger M; Kuczera J; Kruzel E
    Arch Immunol Ther Exp (Warsz); 1980; 28(1):73-82. PubMed ID: 7416921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor cells assayed by numerical and functional tests in chronic renal failure.
    Lortan JE; Kiepiela P; Coovadia HM; Seedat YK
    Kidney Int; 1982 Aug; 22(2):192-7. PubMed ID: 6290745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremia as a state of immune deficiency.
    Birkeland SA
    Scand J Immunol; 1976; 5(1-2):107-15. PubMed ID: 131369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Further investigations on cellular immunodeficiency in uraemic patients and the effect of haemodialysis (author's transl)].
    Reis HE; Cremer W; Heimsoth VH; Graffe-Achelis C; Wetter O
    Klin Wochenschr; 1975 May; 53(10):467-72. PubMed ID: 1195651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-Dihydroxyvitamin D-induced suppressor cells in uremic versus normal lymphocytes.
    Modai D; Weissgarten J; Stelian J; Golik A; Averbukh Z; Peller S; Shaked U; Kaufman S; Tieder M
    Int Arch Allergy Appl Immunol; 1988; 86(4):407-11. PubMed ID: 2970438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of varying dialysis regimens on lymphocyte stimulation.
    Hurst KS; Saldanha LF; Steinberg SM; Galen MA; Lowrie EG; Gagneux SA; Lazarus JM; Strom TB; Carpenter CB; Merrill JP
    Trans Am Soc Artif Intern Organs; 1975; 21():329-34. PubMed ID: 1146004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of suppressor cell activity by cyclosporin A and/or uremic serum in normal versus uremic peripheral blood mononuclear cells.
    Modai D; Berman S; Cohen D; Amit M; Cohn M; Weissgarten J; Averbukh Z
    Int Arch Allergy Appl Immunol; 1990; 91(3):291-6. PubMed ID: 2141326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte subsets in chronic uremic patients treated with maintenance hemodialysis.
    Morra L; Ponassi GA; Gurreri G; Moccia F; Mela GS; Bessone G
    Biomed Pharmacother; 1990; 44(1):53-6. PubMed ID: 1369694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 receptor is similarly expressed by activated lymphocytes from patients on chronic hemodialysis and healthy subjects.
    Modai D; Berman S; Sheleg Y; Cohn M; Weissgarten J; Averbukh Z
    Clin Immunol Immunopathol; 1990 May; 55(2):237-41. PubMed ID: 2138941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production.
    Severini G; Diana L; Di Giovannandrea R; Sagliaschi G
    ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis.
    Lamperi S; Carozzi S
    Nephron; 1986; 44(3):219-25. PubMed ID: 2946966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunosuppressive factor(s) in uremic sera.
    Kamata K; Okubo M; Marumo F
    Proc Clin Dial Transplant Forum; 1980; 10():47-50. PubMed ID: 6981113
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular immunity and lymphocyte populations in developing uremia in the rat.
    Raskova J; Czerwinski DK; Shea SM; Raska K
    J Exp Pathol; 1986; 2(4):229-45. PubMed ID: 2946817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generation.
    Raskova J; Ghobrial I; Shea SM; Ebert EC; Eisinger RP; Raska K
    Diagn Immunol; 1986; 4(4):209-16. PubMed ID: 2944684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concanavalin-A-induced suppressor cell activity in idiopathic membranous nephropathy.
    Matsumoto K; Osakabe K; Katayama H; Yoshizawa N; Seki M; Miyaji H; Nagura Y; Ohi H; Hatano M
    Int Arch Allergy Appl Immunol; 1982; 69(1):26-9. PubMed ID: 6213565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.